Trial Profile
A retrospective study evaluating effect of osteoporosis treatments on areal BMD and on volumetric BMD
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 Jan 2018
Price :
$35
*
At a glance
- Drugs Alendronic acid (Primary) ; Denosumab (Primary) ; Parathyroid hormone (Primary)
- Indications Osteoporosis
- Focus Therapeutic Use
- 19 Jan 2018 New trial record